Table 3.
AUs | Seropositivity | |||
---|---|---|---|---|
Antigen | Geometric mean AU in August 2007 | AU half-life (years) | Proportion seropositive in August 2007 | Seropositivity half-life (years) |
Strongly immunogenic* | ||||
Apical membrane antigen 1 | 11.43 (9.51, 13.75) | 3.71 (3.00, 4.85) | 0.77 (0.75, 0.80) | 49.75 (17.17, 1,099.96) |
Erythrocyte-binding antigen 175 | 3.92 (3.19, 4.81) | 3.79 (3.07, 4.98) | 0.63 (0.60, 0.66) | 24.54 (11.49, 226.94) |
Erythrocyte-binding protein-2 | 2.29 (1.92, 2.74) | 2.76 (2.39, 3.27) | 0.56 (0.53, 0.59) | 8.02 (5.33, 14.70) |
GLURP-R2 | 4.53 (3.83, 5.34) | 3.13 (2.67, 3.78) | 0.72 (0.69, 0.75) | 18.35 (10.97, 57.97) |
Liver-stage antigen-1 | 1.84 (1.65, 2.06) | 6.30 (4.88, 8.90) | 0.65 (0.61, 0.68) | 16.74 (9.19, 76.57) |
MSP-1 (19) | 21.00 (17.28, 25.53) | 2.55 (2.19, 3.06) | 0.82 (0.79, 0.84) | 19.06 (11.58, 48.58) |
MSP-1 (42) | 12.54 (10.42, 15.10) | 3.49 (2.87, 4.43) | 0.79 (0.76, 0.81) | 44.25 (18.93, 442.43) |
Moderately immunogenic† | ||||
GLURPR0 | 0.68 (0.59, 0.77) | 3.53 (2.98, 4.35) | 0.39 (0.36, 0.42) | 5.33 (3.61, 9.80) |
MSP-3 | 0.80 (0.71, 0.90) | 3.25 (2.83, 3.81) | 0.43 (0.40, 0.46) | 5.68 (3.94, 11.07) |
Thrombospondin-related adhesive protein | 0.60 (0.54, 0.66) | 5.55 (4.35, 7.69) | 0.32 (0.29, 0.35) | 8.35 (4.70, 37.32) |
Poorly immunogenic‡ | ||||
Circumsporozoite protein | 0.56 (0.54, 0.58) | 26.59 (14.39, 174.75) | 0.12 (0.10, 0.15) | 2.75 (1.72, 5.91) |
Schizont extract | 0.54 (0.52, 0.55) | 47.62 (21.51, +inf) | 0.07 (0.06, 0.08) | 68.55 (14.66, 2,614.44) |
AU = antibody level. GLURP = Glutamate rich protein; MSP = Merozoite surface protein. Estimates are shown with 95% CIs. +inf corresponds to no reduction in antibody levels.
* Seroprevalence in individuals older than 15 years, > 50% at all time points.
† Seroprevalence in individuals older than 15 years, > 30% but < 70% at all time points.
‡ Seroprevalence in individuals older than 15 years, < 30% at all time points.